[1] MOTTA F, BARONE E, SICA A. Inflammaging and Osteoarthritis. Clin Rev Allergy Immunol. 2023;64(2):222-238.
[2] MARTEL-PELLETIER J, BARR AJ, CICUTTINI FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.
[3] GIORGINO R, ALBANO D, FUSCO S,et al.Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. Int J Mol Sci. 2023;24(7):6405.
[4] KONG P, AHMAD RE, ZULKIFLI A, et al. The role of autophagy in mitigating osteoarthritis progression via regulation of chondrocyte apoptosis: A review. Joint Bone Spine. 2024;91(3):105642.
[5] XU K, HE Y, MOQBEL S, et al. SIRT3 ameliorates osteoarthritis via regulating chondrocyte autophagy and apoptosis through the PI3K/Akt/mTOR pathway. Int J Biol Macromol. 2021;175:351-360.
[6] ZHANG H, YANG Y, WU Y, et al. Unveiling the potential of MSC extracellular vesicles: MiR-122-5p enhancing chondrocyte regeneration in osteoarthritis via autophagy mechanism. Stem Cell Res Ther. 2025;16(1):289.
[7] LU H, JIA C, WU D, et al. Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death Dis. 2021;12(10):865.
[8] ZHANG C, LI Z, LI L, et al. Achyranthoside D (AD) improve intervertebral disc degeneration through affect the autophagy and the activation of PI3K/Akt/mTOR pathway. J Orthop Surg (Hong Kong). 2022;30(3):10225536221135474.
[9] LI J, JIANG M, YU Z, et al. Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage. Cell Mol Biol Lett. 2022;27(1): 62.
[10] CAO W, LI J, YANG K, et al. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer. 2021;108(3):304-322.
[11] WU Y, HOU M, DENG Y, et al. Swimming exercise induces redox-lipid crosstalk to ameliorate osteoarthritis progression. Redox Biol. 2025;81:103535.
[12] LIU Y, HUANG K, ZHOU SL, et al. Engineered exosomal miR140 modulates mitophagy of chondrocytes through targeting CAPN1 to alleviate osteoarthritis. Sci China Life Sci. 2025. doi: 10.1007/s11427-024-2843-7.
[13] MEI Z, LI H, HUANG C, et al. Extracellular vesicles from adipose-derived stromal/stem cells reprogram dendritic cells to alleviate rat TMJOA by transferring mitochondria. J Nanobiotechnology. 2025;23(1):389.
[14] LU M, LOU A, GAO J, et al. Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression. J Orthop Surg Res. 2025;20(1):373.
[15] KOUROUPIS D, KAPLAN LD, BEST TM. Human infrapatellar fat pad mesenchymal stem cells show immunomodulatory exosomal signatures. Sci Rep. 2022;12(1):3609.
[16] 赵洪涛, 王自力, 倘艳峰. 筋骨痛消丸与关节镜联用治疗膝骨关节炎(寒凝血瘀证)的临床研究[J]. 中华中医药学刊,2025,43(12):126-129.
[17] 曹坤燕, 谭新访, 郭艳幸,等. 采用网络药理学与分子对接技术研究筋骨痛消丸治疗髌骨软化症的作用机制[J]. 中国医药导刊,2022,24(9):856-865.
[18] 刘源, 李峰, 史鹏博,等. 筋骨痛消丸调控MLT/SIRT1介导的信号通路治疗膝骨关节炎模型大鼠的研究[J]. 世界中西医结合杂志,2024,19(4):637-642+653.
[19] NAIR AB, JACOB S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31.
[20] 张太平, 姚干. 最适麻醉剂量、方式的实验研究[J]. 青海医药杂志,2001,34(3): 8-9.
[21] 车兆义, 邹悦, 宋清斌. 大鼠实验中几种常用的采血方法探讨[J]. 局解手术学杂志,2008(2):84-85.
[22] MICHAEL JW, SCHLÜTER-BRUST KU, EYSEL P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010; 107(9):152-162.
[23] ETTINGER WH JR, AFABLE RF. Physical disability from knee osteoarthritis: the role of exercise as an intervention. Med Sci Sports Exerc. 1994;26(12):1435-1440.
[24] KATZ JN, ARANT KR, LOESER RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568-578.
[25] BIJLSMA JW, KNAHR K. Strategies for the prevention and management of osteoarthritis of the hip and knee. Best Pract Res Clin Rheumatol. 2007;21(1):59-76.
[26] 谭婉俊, 吴官保, 彭兴宁, 等. 补肾活血汤含药血清调控髓核细胞外泌体中miR-222-3p抑制髓核细胞凋亡的研究[J]. 湖南中医药大学学报,2025,45(3): 425-431.
[27] DANTAS LO, SALVINI TF, MCALINDON TE. Knee osteoarthritis: key treatments and implications for physical therapy. Braz J Phys Ther. 2021;25(2):135-146.
[28] KAN HS, CHAN PK, CHIU KY, et al. Non-surgical treatment of knee osteoarthritis. Hong Kong Med J. 2019;25(2):127-133.
[29] RESTUCCIA R, RUGGIERI D, MAGAUDDA L, et al. The preventive and therapeutic role of physical activity in knee osteoarthritis. Reumatismo. 2022;74(1). doi: 10.4081/reumatismo.2022.1466.
[30] SHTROBLIA V, PETAKH P, KAMYSHNA I, et al. Recent advances in the management of knee osteoarthritis: a narrative review. Front Med (Lausanne). 2025;12: 1523027.
[31] WEI P, BAO R. Intra-Articular Mesenchymal Stem Cell Injection for Knee Osteoarthritis: Mechanisms and Clinical Evidence. Int J Mol Sci. 2022;24(1):59.
[32] WU CL, HARASYMOWICZ NS, KLIMAK MA, et al. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage. 2020;28(5):544-554.
[33] ROSETI L, DESANDO G, CAVALLO C, et al. Articular Cartilage Regeneration in Osteoarthritis. Cells. 2019;8(11):1305.
[34] JIN Y, LI S, YU Q, et al.Application of stem cells in regeneration medicine. MedComm (2020). 2023;4(4):e291.
[35] 工程化组织构建研究热点[J]. 中国组织工程研究,2026,30(5):封底.
[36] WANG Z, LI X, YANG J, et al. Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells. Int J Biol Sci. 2021;17(15):4192-4206.
[37] PRIMORAC D, MOLNAR V, TSOUKAS D, et al. Tissue engineering and future directions in regenerative medicine for knee cartilage repair: a comprehensive review. Croat Med J. 2024;65(3):268-287.
[38] 陈闻波, 蔡江瑜, 孙亚英,等. 应用干细胞旁分泌效应治疗膝部骨关节炎的研究进展[J]. 中国修复重建外科杂志,2019,33(11):1446-1451.
[39] LI T, LI X, HAN G, et al. The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System. Pharmaceutics. 2022;15(1):21.
[40] ZENG H, GUO S, REN X, et al. Current Strategies for Exosome Cargo Loading and Targeting Delivery. Cells. 2023;12(10):1416.
[41] XIONG M, ZHANG Q, HU W, et al. Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery. Front Cell Dev Biol. 2020;8:574223.
[42] WU J, KUANG L, CHEN C, et al. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206: 87-100.
[43] DASHTI A, HOSSEINI HM, MIRHOSSEINI SA. Epsilon toxin induces cytotoxicity by mediating autophagy and apoptosis via the PI3K/AKT/mTOR signaling pathway in A549 cells. Mol Biol Rep. 2025;52(1):403.
[44] ZHANG HP, JIANG RY, ZHU JY, et al. PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer. Breast Cancer. 2024;31(4):539-551.
[45] OMOLEKAN TO, CHAMCHEU JC, BUERGER C, et al. PI3K/AKT/mTOR Signaling Network in Human Health and Diseases. Cells. 2024;13(17):1500.
[46] VERSARI I, SALUCCI S, BAVELLONI A, et al. The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma.Biomolecules. 2025; 15(3):334.
[47] WANG H, SUN P, YUAN X, et al. Autophagy in tumor immune escape and immunotherapy. Mol Cancer. 2025;24(1):85.
[48] KIM J, KUNDU M, VIOLLET B, et al.AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132-141.
[49] HOLCZER M, HAJDÚ B, LŐRINCZ T, et al. Fine-tuning of AMPK-ULK1-mTORC1 regulatory triangle is crucial for autophagy oscillation. Sci Rep. 2020;10(1):17803.
[50] XU J, WANG G, HOU Y, et al. RICTOR-mediated activation of AKT/mTOR signaling and autophagy inhibition promote osteoarthritis. Int Immunopharmacol. 2025; 144:113681.
|